Skip to content

Research at St Andrews

Enhanced efficacy of synergistic combinations of antimicrobial peptides with caspofungin versus Candida albicans in insect and murine models of systemic infection.

Research output: Contribution to journalArticle

Author(s)

Donna MacCallum, Andrew Desbois, Peter John Coote

School/Research organisations

Abstract

Purpose: The objective of this present study was to determine if combinations of antimicrobial peptides (AMPs) with caspofungin display enhanced antifungal activity versus Candida albicans in vitro and in vivo.
Methods: Three conventional AMPs that satisfied criteria favouring their potential development as novel antifungals were selected for investigation. Colistin sulphate was also included as a lipopeptide antibiotic used in the clinic. Minimal inhibitory concentrations were determined for each antifungal agent and checkerboard assays were used to determine fractional inhibitory concentration indices for dual combinations of AMPs or colistin with caspofungin. Viability assays were performed for the same combinations to investigate fungicidal interactions. Synergistic antifungal combinations were then tested for efficacy in vivo and compared to monotherapies in wax moth larva and murine models of systemic C. albicans infection.
Results: In combination with caspofungin, each of the AMPs [hMUC7-12, DsS3(1-16), hLF(1-11)] and colistin were synergistic and candidacidal in vitro. Treatment of infected wax moth larvae with combinations of caspofungin with hMUC7-12, DsS3(1-16) or colistin resulted in significant enhancements in survival compared to treatment with monotherapies. Notably, treatment of C. albicans-infected mice with a combination of caspofungin and DsS3(1-16) resulted in enhancement of survival compared to groups treated with just the individual agents.
Conclusions: This study demonstrates that combination therapies containing caspofungin and AMPs or colistin merit further development as potential novel treatments for C. albicans infections.
Close

Details

Original languageEnglish
JournalEuropean Journal of Clinical Microbiology and Infectious Diseases
Volume32
Issue number4
DOIs
Publication statusPublished - 2013

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Dual β-lactam combination therapy for multi-drug resistant Pseudomonas aeruginosa infection: enhanced efficacy in vivo and comparison with monotherapies of penicillin-binding protein inhibition

    Siriyong, T., Murray, R. M., Bidgood, L. E., Young, S. A., Wright, F., Parcell, B. J., Voravuthikunchai, S. P. & Coote, P. J., 24 Jun 2019, In : Scientific Reports. 9, 13 p., 9098.

    Research output: Contribution to journalArticle

Related by journal

  1. Current mentorship practices in the training of the next generation of clinical microbiology and infectious disease specialists: an international cross-sectional survey

    Ong, D. S. Y., Zapf, T. C., Cevik, M., Palacios-Baena, Z. R., Barać, A., Cimen, C., Maraolo, A. E., Rönnberg, C., Cambau, E., Poljak, M. & Trainee Association of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Apr 2019, In : European Journal of Clinical Microbiology and Infectious Diseases. 38, 4, p. 659-665 7 p.

    Research output: Contribution to journalArticle

  2. Organization and training at national level of antimicrobial stewardship and infection control activities in Europe: an ESCMID cross-sectional survey

    Maraolo, A. E., Ong, D. S. Y., Cimen, C., Howard, P., Kofteridis, D. P., Schouten, J., Mutters, N. T., Pulcini, C. & ESGAP-EUCIC-TAE Working Group on AMS/IPC mapping in Europe, 8 Aug 2019, In : European Journal of Clinical Microbiology and Infectious Diseases. First Online, 8 p.

    Research output: Contribution to journalArticle

ID: 47203823

Top